Praxsyn Corporation (PXYN) Research

Praxsyn Corporation operates as a healthcare enterprise, supplying medical professionals with specific medications and related services for their patients. The company specializes in creating non-narcotic and non-habit-forming treatments, utilizing therapeutic and preventative compounds. These come in various formats, such as transdermal creams, patches, and oral capsules, and are formulated to treat issues like pain management, erectile dysfunction, and metabolic disorders. Praxsyn's offerings are available to patients covered by California's workers' compensation program, along with those under preferred provider contracts. Established in 2005, the company was formerly known as The PAWS Pet Company, Inc. before changing its name to Praxsyn Corporation in March 2014. Its operations are based out of Las Vegas, Nevada.

Market snapshot

Symbol
PXYN
Price
$0.00
Day change
0.00%
Market cap
$6.3K
P/E ratio
-0.01x
52-week range
0.000001-0.00001
Sector
Healthcare
Industry
Medical - Pharmaceuticals

Peer companies

  • DNAPrint Genomics, Inc. (DNAG)
  • Immunotech Laboratories, Inc. (IMMB)
  • Interpharm Holdings, Inc. (IPAH)
  • Jack Nathan Medical Corp. (JNHMF)
  • Lords & Company Worldwide Holdings Inc. (LRDSF)
  • Manhattan Scientifics, Inc. (MHTX)
  • Rising BioSciences, Inc. (RBII)
  • Medical Cannabis Payment Solutions, Inc. (REFG)

Open Praxsyn Corporation (PXYN) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.